Clinical Trial Update: The Effect of Growth Hormone in Very Young Girls With Turner Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating growth hormone in very young girls with Turner syndrome has completed. The study was sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Turner Syndrome

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Turner Syndrome | Phase 3 | Status: COMPLETED